DEFA14A: Others
Apr 26 02:44
DEF 14A: Definitive information statements
Apr 26 02:44
8-K: Current report
Apr 20 04:11
Ligand Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 2 05:12
Ligand Pharmaceuticals | 8-K: Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 27 20:25
Ligand Pharmaceuticals | 8-K: Current report
Jan 8 13:00
Ligand Pharmaceuticals | 8-K: Current report
Dec 1, 2023 21:25
Ligand Pharmaceuticals | 8-K/A: Ligand Reports Third Quarter 2023 Financial Results
Nov 10, 2023 10:48
Ligand Pharmaceuticals | 8-K: Ligand Reports Third Quarter 2023 Financial Results
Nov 9, 2023 05:08
Ligand Pharmaceuticals | 8-K: Current report
Oct 18, 2023 21:03
Ligand Pharmaceuticals | 8-K: Current report
Oct 18, 2023 07:24
Ligand Pharmaceuticals | 8-K: Current report
Sep 27, 2023 20:38
Ligand Pharmaceuticals | 8-K: Current report
Sep 19, 2023 05:26
Ligand Pharmaceuticals | 8-K: Ligand Reports Second Quarter 2023 Financial Results
Aug 9, 2023 04:02
Ligand Pharmaceuticals | 8-K: Current report
Jun 10, 2023 05:00
Ligand Pharmaceuticals | 8-K: Ligand Reports First Quarter 2023 Financial Results
May 5, 2023 04:06
Ligand Pharmaceuticals | DEFA14A: Others
Apr 21, 2023 04:07
Ligand Pharmaceuticals | DEF 14A: Definitive proxy statements
Apr 21, 2023 04:05
Ligand Pharmaceuticals | 8-K: Current report
Mar 13, 2023 20:02
Ligand Pharmaceuticals | 8-K: Ligand Reports Fourth Quarter and Full Year 2022 Financial Results
Feb 23, 2023 05:05
No Data
No Data